Related Experiment Video
Updated: May 29, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Predictors of chronic valvular disease in patients with rheumatic carditis
Murat Muhtar Yilmazer1, Taliha Oner, Vedide Tavlı
1Department of Pediatric Cardiology, Izmir Dr. Behçet Uz Children's Hospital, Izmir, Turkey. drmuratmuhtar@hotmail.com
Insights
Left ventricular dilation predicts persistent valvular disease in children with rheumatic carditis. Early signs like cardiac murmur indicate ongoing mitral regurgitation, impacting long-term outcomes.
Area of Science:
- Pediatric Cardiology
- Rheumatic Heart Disease
- Cardiovascular Research
Background:
- Rheumatic carditis can lead to chronic valvular disease in children.
- Predictors of disease persistence require further investigation for improved management.
- Understanding long-term outcomes is crucial for pediatric cardiac care.
Purpose of the Study:
- To identify predictors of chronic valvular disease in pediatric rheumatic carditis patients.
- To evaluate the association between initial clinical findings and disease progression.
- To determine factors influencing the persistence of valvular involvement and mitral regurgitation.
Main Methods:
- Retrospective review of 88 pediatric patients with chronic rheumatic heart disease.
- Short- to mid-term follow-up data analysis (mean 2.95 years).
- Multivariate logistic regression to identify significant risk factors.
Main Results:
- Initial left ventricular dilation was a significant independent risk factor for persistent valvular involvement or mitral regurgitation.
- Persistence of mitral regurgitation strongly correlated with cardiac murmur at admission.
- No significant correlation found between age, gender, or initial valvular severity and chronic valvular disease.
- Subclinical carditis showed a better outcome than clinically evident carditis.
Conclusions:
- Left ventricular dilation is a key predictor of persistent valvular disease in pediatric rheumatic carditis.
- Cardiac murmur at admission is a marker for ongoing mitral regurgitation.
- Myocardial involvement, independent of valvular regurgitation, may contribute to left ventricular dilation.
Abstract:
This study investigated the predictors of chronic valvular disease in children with rheumatic carditis. The short- to mid-term follow-up records of 88 patients (mean age, 10.68 ± 2.5 years) with chronic rheumatic heart disease were reviewed. The mean follow-up period was 2.95 ± 1.4 years. Valvular involvement completely improved for 24 of the patients (27%) during the follow-up period. The multivariate logistic regression analysis found initial left ventricular dilation to be a significant independent risk factor associated with the persistence of either valvular involvement or mitral regurgitation. Furthermore, persistence of mitral regurgitation was found to be strongly correlated with cardiac murmur at admission. No significant correlation was detected between age, gender, severity of valvular involvements at initial evaluation, and chronic valvular disease. The majority of patients with rheumatic carditis had normal left ventricular systolic function. However, a significant proportion of patients had left ventricular dilation, reported in the medical literature to be associated with the severity of valve involvement. This study found no relation between initial severity of valve involvements and chronic valvular disease. For this reason, increased left ventricular end-diastolic diameter may be secondary to myocardial involvement independent of valvular regurgitation. The findings in this study also suggest that subclinic carditis had a better outcome than clinically evident carditis.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management